X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3428) 3428
Book Review (429) 429
Publication (226) 226
Magazine Article (10) 10
Conference Proceeding (4) 4
Book Chapter (3) 3
Book / eBook (1) 1
Dissertation (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3180) 3180
humans (2188) 2188
male (1759) 1759
animals (1437) 1437
acetamides - therapeutic use (1171) 1171
female (1163) 1163
acetamides - pharmacology (1138) 1138
acetamides - administration & dosage (1044) 1044
pharmacology & pharmacy (1020) 1020
linezolid (983) 983
adult (780) 780
rats (771) 771
middle aged (697) 697
acetamides - adverse effects (590) 590
aged (501) 501
oxazolidinones - therapeutic use (492) 492
treatment outcome (469) 469
acetamides - pharmacokinetics (466) 466
infectious diseases (429) 429
oxazolidinones - administration & dosage (413) 413
mice (408) 408
microbiology (400) 400
dose-response relationship, drug (376) 376
administration, oral (370) 370
pharmacokinetics (318) 318
clinical neurology (313) 313
anti-bacterial agents - therapeutic use (308) 308
time factors (299) 299
adolescent (291) 291
neurosciences (290) 290
efficacy (281) 281
oxazolidinones - pharmacology (278) 278
vancomycin (263) 263
analysis (246) 246
microbial sensitivity tests (238) 238
oxazolidinones - adverse effects (236) 236
anti-bacterial agents - administration & dosage (220) 220
drug therapy (217) 217
staphylococcal infections - drug therapy (211) 211
anti-bacterial agents - pharmacology (208) 208
psychiatry (206) 206
acetamides - chemistry (201) 201
rats, sprague-dawley (200) 200
epilepsy (199) 199
lacosamide (193) 193
safety (192) 192
young adult (189) 189
infections (187) 187
acetamides - blood (184) 184
double-blind method (183) 183
drug therapy, combination (181) 181
oxazolidinones - pharmacokinetics (179) 179
disease models, animal (177) 177
gram-positive bacterial infections - drug therapy (177) 177
oseltamivir (176) 176
child (175) 175
anti-infective agents - therapeutic use (173) 173
antibiotics (172) 172
drug administration schedule (172) 172
health aspects (165) 165
acetamides - metabolism (163) 163
aged, 80 and over (163) 163
abridged index medicus (162) 162
therapy (161) 161
care and treatment (158) 158
anticonvulsants - therapeutic use (157) 157
research (155) 155
internal medicine (151) 151
double-blind (150) 150
agomelatine (149) 149
dosage and administration (149) 149
medicine & public health (149) 149
acetamides - toxicity (146) 146
neurology (144) 144
acetamides (142) 142
anti-infective agents - administration & dosage (140) 140
liver - drug effects (139) 139
retrospective studies (139) 139
toxicology (131) 131
rats, wistar (130) 130
seizures (130) 130
drugs (128) 128
immunology (128) 128
chemistry, medicinal (124) 124
partial-onset seizures (124) 124
staphylococcus aureus - drug effects (124) 124
antiviral agents - therapeutic use (122) 122
staphylococcal infections - microbiology (122) 122
staphylococcus aureus (122) 122
pharmacology (120) 120
influenza, human - drug therapy (119) 119
vancomycin - therapeutic use (119) 119
child, preschool (118) 118
oxazolidinones (118) 118
liver - metabolism (116) 116
antiepileptic drugs (114) 114
anticonvulsants - administration & dosage (113) 113
drug interactions (113) 113
methicillin resistance (111) 111
drug resistance (110) 110
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3245) 3245
German (40) 40
Japanese (37) 37
French (27) 27
Russian (21) 21
Spanish (19) 19
Italian (14) 14
Chinese (9) 9
Swedish (7) 7
Portuguese (6) 6
Dutch (4) 4
Czech (3) 3
Hungarian (3) 3
Norwegian (3) 3
Danish (2) 2
Bulgarian (1) 1
Croatian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2014, Volume 370, Issue 23, pp. 2169 - 2179
Journal Article
Analytical and Bioanalytical Chemistry, ISSN 1618-2642, 4/2018, Volume 410, Issue 11, pp. 2815 - 2828
Generation of skin distribution profiles and reliable determination of drug molecule concentration in the target region are crucial during the development... 
Biochemistry, general | Skin penetration | Food Science | Quantification | Drug distribution | Mass spectrometry imaging | Human skin | Laboratory Medicine | MALDI-MSI | Chemistry | Analytical Chemistry | Monitoring/Environmental Analysis | Characterization and Evaluation of Materials | CHEMISTRY, ANALYTICAL | HUMAN STRATUM-CORNEUM | BIOCHEMICAL RESEARCH METHODS | PENETRATION | MOLECULAR-SIZE | MICROSCOPY | MASS-SPECTROMETRY | TISSUE-SECTIONS | ATOPIC-DERMATITIS | PERCUTANEOUS-ABSORPTION | PSORIASIS | Pyrroles - pharmacokinetics | Benzamides - pharmacokinetics | Skin - metabolism | Humans | Aminopyridines - pharmacokinetics | Pyridines - pharmacokinetics | Drug Discovery - methods | Benzamides - administration & dosage | Cyclopropanes - administration & dosage | Phosphodiesterase 4 Inhibitors - administration & dosage | Pyrroles - administration & dosage | Piperidines - pharmacokinetics | Pyrazoles - pharmacokinetics | Cyclopropanes - pharmacokinetics | Protein Kinase Inhibitors - pharmacokinetics | Aminopyridines - administration & dosage | Piperidines - administration & dosage | Pyridines - administration & dosage | Acetamides - pharmacokinetics | Phosphodiesterase 4 Inhibitors - pharmacokinetics | Pyrimidines - administration & dosage | Skin Absorption | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods | Protein Kinase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Pyrimidines - pharmacokinetics | Administration, Topical | Acetamides - administration & dosage | Pharmaceutical research | Topical medication | Pharmaceutical industry | Innovations | Testing | Formulations | Explants | Psoriasis | Medical treatment | Spatial discrimination | Imaging techniques | Ions | Mass spectroscopy | Desorption | Drug development | Tissues | Dermatitis | Ionization | Lasers | Atopic dermatitis | Imaging | Skin diseases | Skin | Mass spectrometry | Spatial resolution | Physicochemical properties | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2013, Volume 57, Issue 2, pp. 855 - 863
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
SOFT-TISSUE INFECTIONS | STREPTOCOCCUS-PYOGENES | DOSE PHARMACOKINETICS | ANTIBACTERIAL ACTIVITY | MOUSE MODEL | ECONOMIC OUTCOMES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | LENGTH-OF-STAY | MURINE THIGH INFECTION | COMPLICATED SKIN | TRIMETHOPRIM-SULFAMETHOXAZOLE | Linezolid | Skin - microbiology | Mupirocin - administration & dosage | Male | Luminescent Measurements | Mupirocin - therapeutic use | Oxazolidinones - administration & dosage | Skin - injuries | Oxazolidinones - therapeutic use | Anti-Bacterial Agents - therapeutic use | Doxycycline - administration & dosage | Staphylococcal Skin Infections - drug therapy | Acetamides - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Clindamycin - administration & dosage | Community-Acquired Infections - drug therapy | Diabetes Mellitus, Type 2 | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Wound Healing - drug effects | Daptomycin - therapeutic use | Disease Models, Animal | Staphylococcal Infections - drug therapy | Vancomycin - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Administration, Oral | Doxycycline - therapeutic use | Methicillin-Resistant Staphylococcus aureus - drug effects | Mice, Inbred C57BL | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Bacterial Load | Clindamycin - therapeutic use | Animals | Soft Tissue Infections - microbiology | Vancomycin - therapeutic use | Mice | Administration, Topical | Anti-Bacterial Agents - administration & dosage | Community-Acquired Infections - microbiology | Staphylococcal Skin Infections - microbiology | Daptomycin - administration & dosage | Acetamides - administration & dosage | Index Medicus | Animal models | Bioluminescence | Intravenous administration | Image processing | Clindamycin | Vancomycin | Cellulitis | Drug resistance | Polyethylene glycol | Surgery | daptomycin | Ointments | Wound infection | Wound healing | Diabetes mellitus | Antimicrobial agents | Folliculitis | Mupirocin | imaging | Soft tissues | Drainage | Photography | Antibiotics | trimethoprim-sulfamethoxazole | Ulcers | Doxycycline | Impetigo | Skin | Experimental Therapeutics
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2015, Volume 112, Issue 40, pp. 12468 - 12473
Journal Article
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 12/2017, Volume 83, Issue 12, pp. 2778 - 2788
AimsBased on in vitro data, there is evidence to suggest that cytochrome P450 (CYP) 2C8 is involved in the metabolism of selexipag and its active metabolite,... 
pharmacokinetics | rifampicin | selexipag | CYP2C8 | drug interactions | gemfibrozil | PULMONARY ARTERIAL-HYPERTENSION | TREPROSTINIL | REPAGLINIDE | CLOPIDOGREL | CONCISE GUIDE | PHARMACOLOGY | TOLERABILITY | PROSTACYCLIN RECEPTOR AGONIST | PHARMACOLOGY & PHARMACY | INHIBITOR | Prodrugs - administration & dosage | Activation, Metabolic | Cytochrome P-450 CYP2C8 Inhibitors - administration & dosage | Acetates - adverse effects | Acetates - blood | Area Under Curve | Humans | Middle Aged | Pyrazines - administration & dosage | Antihypertensive Agents - administration & dosage | Half-Life | Male | Metabolic Clearance Rate | Gemfibrozil - adverse effects | Healthy Volunteers | Acetamides - blood | Young Adult | Rifampin - adverse effects | Drug Interactions | Acetamides - adverse effects | Cytochrome P-450 CYP2C8 Inducers - adverse effects | Adult | Cytochrome P-450 CYP2C8 - metabolism | Rifampin - administration & dosage | Gemfibrozil - administration & dosage | Cytochrome P-450 CYP2C8 Inducers - administration & dosage | Acetamides - pharmacokinetics | Risk Assessment | Cytochrome P-450 CYP2C8 Inhibitors - adverse effects | Antihypertensive Agents - pharmacokinetics | Antihypertensive Agents - adverse effects | Antihypertensive Agents - blood | Cross-Over Studies | Prodrugs - adverse effects | Acetates - administration & dosage | Prodrugs - pharmacokinetics | Pyrazines - pharmacokinetics | Adolescent | Pyrazines - adverse effects | Pyrazines - blood | Germany | Acetamides - administration & dosage | Acetates - pharmacokinetics | Metabolites | Gemfibrozil | Cytochrome P-450 | Nausea | Drug therapy, Combination | Rifampin | Fibric acids | Index Medicus
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 2012, Volume 9, Issue 10, pp. 2933 - 2941
We evaluated the potential of poly(N-vinylacetamide-co-acrylic acid) modified with D-octaarginine, which is a typical cell-penetrating peptide, as a carrier... 
IMMUNITY | mucosal vaccine delivery | VIRUS-INFECTION | B SUBUNIT | oligoarginine | poly(N-vinylacetamide-co-acrylic acid) | INTRANASAL | cell-penetrating peptide | cell-penetrating peptide-linked polymer | ADJUVANT | HEAT-LABILE TOXIN | A VIRUS | NANOPARTICLES | TRACE AMOUNT | PHARMACOLOGY & PHARMACY | NASAL INFLUENZA VACCINE | Adjuvants, Immunologic - administration & dosage | Ovalbumin - immunology | Immunity, Humoral - immunology | Drug Carriers - administration & dosage | Administration, Intranasal - methods | Vaccines - chemistry | Cholera Toxin - immunology | Mucous Membrane - drug effects | Acetamides - immunology | Nasal Mucosa - drug effects | Antibody Formation - immunology | Acrylates - chemistry | Immunoglobulin A, Secretory - immunology | Acrylates - administration & dosage | Antigens - chemistry | Acetamides - chemistry | Pharmaceutical Solutions - administration & dosage | Mice | Mice, Inbred BALB C | Cell-Penetrating Peptides - administration & dosage | Vaccines - administration & dosage | Polymers - administration & dosage | Influenza Vaccines - administration & dosage | Epithelial Cells - metabolism | Epithelial Cells - drug effects | Pharmaceutical Solutions - chemistry | Drug Carriers - chemistry | Antigens - administration & dosage | Vaccination - methods | Adjuvants, Immunologic - chemistry | Immunoglobulin G - immunology | Female | Cell-Penetrating Peptides - immunology | Nasal Mucosa - metabolism | Cell-Penetrating Peptides - chemistry | Acrylates - immunology | Mucous Membrane - metabolism | Animals | Influenza Vaccines - immunology | Polyvinyls - administration & dosage | Mucous Membrane - immunology | Nasal Mucosa - immunology | Epithelial Cells - immunology | Influenza Vaccines - chemistry | Antigens - immunology | Polymers - chemistry | Drug Delivery Systems - methods | Polyvinyls - chemistry | Acetamides - administration & dosage | Index Medicus
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2014, Volume 58, Issue 3, pp. 1284 - 1293
Journal Article
Neuropharmacology, ISSN 0028-3908, 03/2017, Volume 114, pp. 156 - 167
Although opioids are highly efficacious analgesics, their abuse potential and other untoward side effects diminish their therapeutic utility. The addition of... 
Self-administration | 2-arachidonyl glycerol (2-AG) | Pain | Fatty acid amide hydrolase (FAAH) | Monoacylglycerol lipase (MAGL) | Morphine | Anandamide (AEA) | Cannabinoid | Heroin | RAT | MONOACYLGLYCEROL LIPASE | CB2 RECEPTOR | NEUROPATHIC PAIN MODEL | NEUROSCIENCES | PERIPHERAL CANNABINOID RECEPTORS | NUCLEUS-ACCUMBENS | ACID AMIDE HYDROLASE | OPIOID WITHDRAWAL SYMPTOMS | PHARMACOLOGY & PHARMACY | MODULATION | CHRONIC NONCANCER PAIN | Endocannabinoids - metabolism | Inflammation - chemically induced | Arachidonic Acid - metabolism | Sciatic Nerve - injuries | Receptor, Cannabinoid, CB2 - physiology | Male | Carbamates - administration & dosage | Receptor, Cannabinoid, CB2 - genetics | Receptor, Cannabinoid, CB1 - physiology | Dose-Response Relationship, Drug | Inflammation - complications | Arachidonic Acids - metabolism | Self Administration | Neuralgia - prevention & control | Neuralgia - etiology | Heroin - administration & dosage | Mice, Inbred C57BL | Analgesics - administration & dosage | Hyperalgesia - prevention & control | Glycerides - metabolism | Polyunsaturated Alkamides - metabolism | Drug-Seeking Behavior - drug effects | Mice, Knockout | Hydrolysis | Animals | Receptor, Cannabinoid, CB1 - genetics | Analgesics, Opioid - administration & dosage | Mice | Carrageenan | Morphine - administration & dosage | Acetamides - administration & dosage | Drug abuse | Care and treatment | Carrageenin | Glycerol | Lipase | Fatty acids | Glycerin | Liability (Law) | Analysis | Physiological aspects | Index Medicus | pain | heroin | fatty acid amide hydrolase (FAAH) | self-administration | anandamide (AEA) | cannabinoid | monoacylglycerol lipase (MAGL) | morphine
Journal Article